Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Personalized Biomedical Risk Assessment for Smoking Cessation in Chronic Obstructive Pulmonary Disease

NCT04119934 is registered in ClinicalTrials.gov with Unity Health Toronto as lead sponsor.

NCT NCT04119934
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04119934 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Personalized Biomedical Risk Assessment for Smoking Cessation in Chronic Obstructive Pulmonary Disease
Lead sponsor
Unity Health Toronto
Phase
Observational
Overall status
Completed
Start date
January 9, 2023
Completion date
July 31, 2024
Enrollment
83 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease (copd), smoking cessation